These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4625628)

  • 1. Cross-resistance of Pseudomonas to gentamicin and tobramycin.
    Brusch JL; Barza M; Bergeron MG; Weinstein L
    Antimicrob Agents Chemother; 1972 Mar; 1(3):280-1. PubMed ID: 4625628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobramycin: in vitro antibacterial spectrum of a new aminoglycoside.
    Meyers BR; Hirschman SZ
    J Clin Pharmacol New Drugs; 1972; 12(8):313-20. PubMed ID: 4626620
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.
    Traub WH; Raymond EA
    Appl Microbiol; 1972 Jan; 23(1):4-7. PubMed ID: 4621796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.
    Klastersky J; Henri A; Vandenborre L
    Am J Med Sci; 1973 Jul; 266(1):13-21. PubMed ID: 4198684
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of tobramycin and gentamicin with special reference to anti-pseudomonas activity.
    Klastersky J; Daneau D; de Maertelaer V
    Clin Pharmacol Ther; 1973; 14(1):104-11. PubMed ID: 4630232
    [No Abstract]   [Full Text] [Related]  

  • 6. Tobramycin: bacteriological evaluation.
    Burger LM; Sanford JP; Zweighaft T
    Am J Med Sci; 1973 Feb; 265(2):135-42. PubMed ID: 4196741
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tobramycin-gentamicin: the To-Ge pretext of aminoside antibiotics].
    Morel C; Freymuth F
    Nouv Presse Med; 1973 Jan; 2(4):246. PubMed ID: 4568329
    [No Abstract]   [Full Text] [Related]  

  • 9. Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.
    Meyer RD; Young LS; Armstrong D
    Appl Microbiol; 1971 Dec; 22(6):1147-51. PubMed ID: 5002900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
    Phillips I; King A; Shannon K
    Am J Med; 1986 Jun; 80(6B):48-55. PubMed ID: 3728534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of nonfermentative gram-negative bacilli to tobramycin.
    Uwaydah M; Taqi-Eddin AR
    J Infect Dis; 1976 Aug; 134 Suppl():S28-32. PubMed ID: 823278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in-vitro activity of tobramycin compared with that of other aminoglycosides.
    Waterworth PM
    J Clin Pathol; 1972 Nov; 25(11):979-83. PubMed ID: 4648543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism.
    Zimelis VM; Jackson GG
    J Infect Dis; 1973 Jun; 127(6):663-9. PubMed ID: 4196445
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.
    Kluge RM; Standiford HC; Tatem B; Young VM; Greene WH; Schimpff SC; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1974 Oct; 6(4):442-6. PubMed ID: 4157342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
    Murray PR
    Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of tobramycin on Pseudomonas keratitis.
    Smolin G; Okumoto M; Wilson FM
    Am J Ophthalmol; 1973 Oct; 76(4):555-60. PubMed ID: 4200625
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
    Meyer RD; Draus LL; Pasieczinik KA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.